POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company Information

Contact top employees from POINT Biopharma, a wholly owned subsi...

Summary

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company is a private company that has been in the industry for 7 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Joe McCann. Its headquarters is located at Toronto, Ontario, CA. The number of employees ranges from 1 to 25. The annual revenue of POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company varies between 100K and 5.0M. Total funding of the company - $20M. To connect with POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company employee register on SignalHire.

Organization Website

pointbiopharma.com

Social Links

facebooklinkedIntwitter

Phone Number

647-812-2417, (317) 543-9957

Industries

Headquarters Location

4850 W 78th St, Indianapolis, Indiana, 46268 US

Employees Size

100-200 employees

Specialties

Radioligand, Radiopharmaceutical, Cancer, Oncology

Founded

2019

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Merger Pending

Competitors

Founded
Type
Employees
Revenue
Funding
1998Public
Company
100 - 250 57.8M $405.9M
2018Privately
Held
1 - 25 < 1M $534M
2020Privately
Held
1 - 25 < 1M $258M
2019- 1 - 25 1.3M $11M

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company shows a diverse range of experience levels:
4% have been with the company for less than 1 year19% for 1–2 years48% for 3–4 years22% for 5–7 years4% for 8–10 years4% have over 11 years of service at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
Ex-employees positions
In Company
In New Company
Contact top employees from POINT Biopharma, a wholly owned subsi...

FAQ

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company operates in the Biotech industries. More details can be found on the official website: pointbiopharma.com.
The headquarters of POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company are located in Indianapolis, United States.
The current CEO of POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company is Joe McCann
You can contact POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company by phone at 647-812-2417, (317) 543-9957.
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company currently employs 100-200 people.
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company's revenue is approximately 2.3M.
Well-known competitors of POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company include Cytokinetics, Day One Biopharmaceuticals, RayzeBio and Alpha-9 Oncology.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP